Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease.

OBJECTIVE To determine if baseline measurements of cerebral atrophy and severity of white matter hyperintensity (WMH) predict the rate of future cognitive decline in patients with Alzheimer disease (AD). DESIGN Data were drawn from the Predictors Study, a longitudinal study that enrolls patients with mild AD and reassesses them every 6 months with use of the Columbia modified Mini-Mental State (mMMS) examination (score range, 0-57). Magnetic resonance images were analyzed to determine the severity of WMH, using the Scheltens scale, and the degree of atrophy, using the bicaudate ratio. Generalized estimating equations were used to determine whether severity of baseline magnetic resonance image measurements and their interaction predicted the rate of mMMS score decline at subsequent visits. SETTING Three university-based AD centers in the United States. PARTICIPANTS At baseline, 84 patients with AD from the Predictors Study received structural magnetic resonance imaging and were selected for analysis. They had a mean of 6 follow-up evaluations. Main Outcome Measure The mMMS score. RESULTS Generalized estimating equation models demonstrated that the degree of baseline atrophy (beta = -0.316; P = .04), the severity of WMH (beta = -0.173; P = .03), and their interaction (beta = -6.061; P = .02) predicted the rate of decline in mMMS scores. CONCLUSIONS Both degree of cerebral atrophy and severity of WMH are associated with the rapidity of cognitive decline in AD. Atrophy and WMH may have a synergistic effect on future decline in AD, such that patients with a high degree of both have a particularly precipitous cognitive course. These findings lend further support to the hypothesis that cerebrovascular pathological abnormalities contribute to the clinical syndrome of AD.

[1]  W. M. van der Flier,et al.  Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD , 2004, Neurology.

[2]  Sharon E. Lee,et al.  Ventricular volume and dementia progression in the Cardiovascular Health Study , 2007, Neurobiology of Aging.

[3]  Nick C Fox,et al.  Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.

[4]  J. Toole,et al.  The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. , 1997, Neuroepidemiology.

[5]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[6]  P. Scheltens,et al.  A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging , 1993, Journal of the Neurological Sciences.

[7]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[8]  A. Convit,et al.  Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[9]  J. Brandt,et al.  Motor signs during the course of Alzheimer disease , 2004, Neurology.

[10]  Elisabet Englund,et al.  Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia , 1998, Dementia and Geriatric Cognitive Disorders.

[11]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[12]  M N Rossor,et al.  Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.

[13]  D. Marcus,et al.  White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. , 2005, Archives of neurology.

[14]  N. Schuff,et al.  Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer's disease , 2006, Neuroscience Letters.

[15]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[16]  Steven H. Ferris,et al.  Alzheimer's Disease: Longitudinal CT , 1989 .

[17]  E. Mori,et al.  Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease: A Quantitative Study , 2000, Stroke.

[18]  G. Harrer,et al.  Bicaudate index on magnetic resonance imaging: effects of normal aging. , 1994 .

[19]  F. Gunning-Dixon,et al.  The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. , 2000, Neuropsychology.

[20]  M. Kameyama,et al.  White Matter Lesions and Dementia MRI‐Pathological Correlation , 2002, Annals of the New York Academy of Sciences.

[21]  Yaakov Stern,et al.  Modified Mini-Mental State Examination: Validity and Reliability , 1987 .

[22]  W. M. van der Flier,et al.  Shifting Paradigms in Dementia , 2007, Annals of the New York Academy of Sciences.

[23]  J M Wardlaw,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[24]  Robert Moulias,et al.  Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly , 2002, Acta Neuropathologica.

[25]  B. Horwitz,et al.  Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: Correlations with disease severity , 1993, Biological Psychiatry.

[26]  G. Schroth,et al.  Early diagnosis of herpes simplex encephalitis by MRI , 1987, Neurology.

[27]  D. Leys,et al.  Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. , 1990, Archives of neurology.

[28]  R. D'Agostino,et al.  Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. , 2006, Archives of neurology.

[29]  Laura Mickes,et al.  Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. , 2002, Archives of neurology.

[30]  J. Lodder,et al.  Interobserver agreement in the assessment of cerebral atrophy on CT using bicaudate and sylvian-fissure ratios , 1999, Neuroradiology.

[31]  M. Buchsbaum,et al.  3.29 – Alzheimer’s Disease: Neurostructures , 2008 .

[32]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[33]  M. Albert,et al.  Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). II. Neurological, Psychiatric, and Demographic Influences on Baseline Measures of Disease Severity , 1993, Alzheimer disease and associated disorders.

[34]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[35]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[36]  G. Fein,et al.  Tissue segmentation of the brain in Alzheimer disease. , 1997, AJNR. American journal of neuroradiology.

[37]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[38]  G. Dobben,et al.  Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy , 1978, Neurology.

[39]  T. Bekinschtein,et al.  White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  Kei Yamada,et al.  Do White Matter Changes Have Clinical Significance in Alzheimer’s Disease? , 2004, Gerontology.

[41]  Eric E. Smith,et al.  Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy , 2006, Neurology.

[42]  Robert Barber,et al.  Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. , 2002, Archives of general psychiatry.

[43]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[44]  J. Kaye,et al.  Predicting the rate of cognitive decline in aging and early Alzheimer disease , 2004, Neurology.

[45]  M. Albert,et al.  Application of a growth curve approach to modeling the progression of Alzheimer's disease. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[46]  A. Hofman,et al.  Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions , 2004, Annals of neurology.

[47]  M. Albert,et al.  Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite Comparisons , 1993, Alzheimer disease and associated disorders.

[48]  K. Krishnan,et al.  Bicaudate Index on Magnetic Resonance Imaging: Effects of Normal Aging , 1994, Journal of geriatric psychiatry and neurology.

[49]  C. DeCarli,et al.  Predictors of brain morphology for the men of the NHLBI twin study. , 1999, Stroke.

[50]  M. Mascalchi,et al.  Alzheimer’s Disease: Role of Size and Location of White Matter Changes in Determining Cognitive Deficits , 2005, Dementia and Geriatric Cognitive Disorders.

[51]  Donald H. Lee,et al.  Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. , 1994, Archives of neurology.

[52]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[53]  Norbert Schuff,et al.  Neuropathological basis of magnetic resonance images in aging and dementia , 2008, Annals of neurology.

[54]  Nick C Fox,et al.  Rates of global and regional cerebral atrophy in AD and frontotemporal dementia , 2001, Neurology.

[55]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[56]  S. Leurgans,et al.  MRI predictors of risk of incident Alzheimer disease , 2005, Neurology.

[57]  J. Brandt,et al.  Motor signs predict poor outcomes in Alzheimer disease , 2005, Neurology.

[58]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.